About Aignostics
Aignostics is a company based in Berlin (Germany) founded in 2018 by Frederick Klauschen, Maximilian Alber, Viktor Matyas, and Klaus-Robert Muller.. Aignostics has raised $53.89 million across 3 funding rounds from investors including Mayo Clinic, Athos and High-Tech Gründerfonds. The company has 25 employees as of December 31, 2021. Aignostics offers products and services including Foundation Models, Atlas H&E-TME, Target & Biomarker Discovery, Translational Research, and Digital Diagnostics. Aignostics operates in a competitive market with competitors including PathAI, Deepcell, Pictor Labs, Neko Health and Ovizio, among others.
- Headquarter Berlin, Germany
- Employees 25 as on 31 Dec, 2021
- Founders Frederick Klauschen, Maximilian Alber, Viktor Matyas, Klaus-Robert Muller
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aignostics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$53.89 M (USD)
in 3 rounds
-
Latest Funding Round
$34 M (USD), Series B
Oct 29, 2024
-
Investors
Mayo Clinic
& 8 more
-
Employee Count
25
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aignostics
Aignostics offers a comprehensive portfolio of products and services, including Foundation Models, Atlas H&E-TME, Target & Biomarker Discovery, Translational Research, and Digital Diagnostics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tools for generating embeddings in pathology workflows.
Application for comprehensive tumor microenvironment analysis.
Service to identify drug targets using multimodal datasets.
Service for measuring biomarkers across data modalities.
Tools to refine models for real-world clinical applications.
Unlock access to complete
Funding Insights of Aignostics
Aignostics has successfully raised a total of $53.89M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $34 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $34.0M
-
First Round
First Round
(28 Aug 2020)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series B - Aignostics | Valuation | Athos | |
| Sep, 2022 | Amount | Series A - Aignostics | Valuation | Wellington Partners Venture Capital | |
| Aug, 2020 | Amount | Seed - Aignostics | Valuation | Boehringer Ingelheim Venture Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aignostics
Aignostics has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Mayo Clinic, Athos and High-Tech Gründerfonds. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Founded Year | Domain | Location | |
|
Healthcare investments are targeted by Boehringer Ingelheim Venture Fund.
|
Founded Year | Domain | Location | |
|
Early-stage investments are provided for life science and healthcare innovations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aignostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aignostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aignostics Comparisons
Competitors of Aignostics
Aignostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Deepcell, Pictor Labs, Neko Health and Ovizio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
AI-based tools for pathological image analysis are provided to labs.
|
|
| domain | founded_year | HQ Location |
Platform offering solutions for preventive health scans
|
|
| domain | founded_year | HQ Location |
Imaging systems and AI software for microscopes are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aignostics
Frequently Asked Questions about Aignostics
When was Aignostics founded?
Aignostics was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Aignostics located?
Aignostics is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Is Aignostics a funded company?
Aignostics is a funded company, having raised a total of $53.89M across 3 funding rounds to date. The company's 1st funding round was a Seed of $5.91M, raised on Aug 28, 2020.
How many employees does Aignostics have?
As of Dec 31, 2021, the latest employee count at Aignostics is 25.
What does Aignostics do?
Aignostics was founded in 2018 in Berlin, Germany, as a provider of AI-based software for pathology diagnostics. Patented technology is utilized to reverse-engineer AI models, enabling explainable results through heatmaps and image overlays. The software supports diagnostic processes in healthcare and extends to drug research, where microscopic visual estimations are analyzed and quantified. Operations focus on the healthcare and biotechnology sectors.
Who are the top competitors of Aignostics?
Aignostics's top competitors include Pictor Labs, PathAI and Neko Health.
What products or services does Aignostics offer?
Aignostics offers Foundation Models, Atlas H&E-TME, Target & Biomarker Discovery, Translational Research, and Digital Diagnostics.
Who are Aignostics's investors?
Aignostics has 9 investors. Key investors include Mayo Clinic, Athos, High-Tech Gründerfonds, Wellington Partners, and Boehringer Ingelheim Venture Fund.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.